VTVT
vTv Therapeutics Inc - Ordinary Shares - Class A

14,777
Mkt Cap
$143.8M
Volume
7,071.00
52W High
$35.23
52W Low
$13.15
PE Ratio
-10.35
VTVT Fundamentals
Price
$34.10
Prev Close
$34.41
Open
$35.95
50D MA
$25.32
Beta
0.87
Avg. Volume
13,154.42
EPS (Annual)
-$3.20
P/B
1.92
Rev/Employee
$44,217.39
Loading...
Loading...
News
all
press releases
vTv Therapeutics (NASDAQ:VTVT) Stock Crosses Above Fifty Day Moving Average - Here's What Happened
vTv Therapeutics (NASDAQ:VTVT) Stock Crosses Above 50 Day Moving Average - Here's Why...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Above 50-Day Moving Average - Here's Why
vTv Therapeutics (NASDAQ:VTVT) Stock Crosses Above 50 Day Moving Average - Time to Sell...
MarketBeat·14d ago
News Placeholder
Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in vTv Therapeutics (VTVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·17d ago
News Placeholder
vTv Therapeutics (NASDAQ:VTVT) Raised to Strong-Buy at BTIG Research
BTIG Research upgraded shares of vTv Therapeutics to a "strong-buy" rating in a report on Tuesday...
MarketBeat·20d ago
News Placeholder
All You Need to Know About vTv Therapeutics (VTVT) Rating Upgrade to Buy
vTv Therapeutics (VTVT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·1mo ago
News Placeholder
Q1 Earnings Estimate for VTVT Issued By HC Wainwright
vTv Therapeutics Inc. (NASDAQ:VTVT - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for vTv Therapeutics in a research note issued to investors on...
MarketBeat·1mo ago
News Placeholder
vTv Therapeutics (NASDAQ:VTVT) Releases Earnings Results, Misses Estimates By $0.11 EPS
vTv Therapeutics (NASDAQ:VTVT - Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported ($1.08) earnings per share for the quarter, missing the...
MarketBeat·1mo ago

Latest VTVT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.